FFCP PHASE1:Mm9::chr17:48463693..48463711,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr17:48463693..48463711,-|id=chr17:48463693..48463711,-|ontology_enrichment_celltype=CL:0000355!1.54e-10!9|ontology_enrichment_celltype_v019_2=CL:0000355,2.95e-15,9|ontology_enrichment_disease=DOID:0060100!3.62e-30!3;DOID:4045!3.62e-30!3;DOID:0050686!1.79e-15!6|ontology_enrichment_disease_v019_2=DOID:0060100,6.41e-44,3;DOID:4045,6.41e-44,3;DOID:0050686,1.89e-22,6|ontology_enrichment_uberon=UBERON:0001134!1.54e-10!9;UBERON:0002036!1.54e-10!9;UBERON:0002385!1.54e-10!9;UBERON:0000486!1.54e-10!9;UBERON:0001015!1.54e-10!9;UBERON:0004290!1.54e-10!9;UBERON:0003082!1.54e-10!9;UBERON:0000383!1.51e-09!10;UBERON:0002329!9.84e-09!11;UBERON:0003077!9.84e-09!11;UBERON:0003059!9.84e-09!11;UBERON:0007282!9.84e-09!11;UBERON:0009618!9.84e-09!11;UBERON:0007285!9.84e-09!11|ontology_enrichment_uberon_v019_2=UBERON:0001134,2.95e-15,9;UBERON:0002036,2.95e-15,9;UBERON:0002385,2.95e-15,9;UBERON:0000486,2.95e-15,9;UBERON:0007503,2.95e-15,9;UBERON:0001015,2.95e-15,9;UBERON:0002329,2.95e-15,9;UBERON:0003082,2.95e-15,9;UBERON:0003059,2.95e-15,9;UBERON:0007282,2.95e-15,9;UBERON:0004290,2.95e-15,9;UBERON:0009618,2.95e-15,9;UBERON:0000383,8.21e-14,10;UBERON:0007524,1.25e-12,11;UBERON:0003077,1.25e-12,11;UBERON:0007285,1.25e-12,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14.6486070757918,15.626706890476,5.75876118371178,31.7645003536748,9.56263678941824,7.76816564849846,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11981512450592,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.257347907114715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.170870880797853,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr17:48463693..48463711,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr17:48463693..48463711,- | |||
|description=CAGE_peak_at_chr17:48463693..48463711,- | |||
|id=chr17:48463693..48463711,- | |||
|ontology_enrichment_celltype=CL:0000355!1.54e-10!9 | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,2.95e-15,9 | |||
|ontology_enrichment_disease=DOID:0060100!3.62e-30!3;DOID:4045!3.62e-30!3;DOID:0050686!1.79e-15!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,6.41e-44,3;DOID:4045,6.41e-44,3;DOID:0050686,1.89e-22,6 | |||
|ontology_enrichment_uberon=UBERON:0001134!1.54e-10!9;UBERON:0002036!1.54e-10!9;UBERON:0002385!1.54e-10!9;UBERON:0000486!1.54e-10!9;UBERON:0001015!1.54e-10!9;UBERON:0004290!1.54e-10!9;UBERON:0003082!1.54e-10!9;UBERON:0000383!1.51e-09!10;UBERON:0002329!9.84e-09!11;UBERON:0003077!9.84e-09!11;UBERON:0003059!9.84e-09!11;UBERON:0007282!9.84e-09!11;UBERON:0009618!9.84e-09!11;UBERON:0007285!9.84e-09!11 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,2.95e-15,9;UBERON:0002036,2.95e-15,9;UBERON:0002385,2.95e-15,9;UBERON:0000486,2.95e-15,9;UBERON:0007503,2.95e-15,9;UBERON:0001015,2.95e-15,9;UBERON:0002329,2.95e-15,9;UBERON:0003082,2.95e-15,9;UBERON:0003059,2.95e-15,9;UBERON:0007282,2.95e-15,9;UBERON:0004290,2.95e-15,9;UBERON:0009618,2.95e-15,9;UBERON:0000383,8.21e-14,10;UBERON:0007524,1.25e-12,11;UBERON:0003077,1.25e-12,11;UBERON:0007285,1.25e-12,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14.6486070757918,15.626706890476,5.75876118371178,31.7645003536748,9.56263678941824,7.76816564849846,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11981512450592,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.257347907114715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.170870880797853,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr17:48463693..48463711,- | |||
}} |
Latest revision as of 01:19, 5 August 2015
Short description: | p@chr17:48463693..48463711, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr17:48463693..48463711, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 2.95e-15 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 2.95e-15 | 9 |
striated muscle tissue | 2.95e-15 | 9 |
muscle tissue | 2.95e-15 | 9 |
multilaminar epithelium | 2.95e-15 | 9 |
epithelial vesicle | 2.95e-15 | 9 |
musculature | 2.95e-15 | 9 |
somite | 2.95e-15 | 9 |
myotome | 2.95e-15 | 9 |
presomitic mesoderm | 2.95e-15 | 9 |
presumptive segmental plate | 2.95e-15 | 9 |
dermomyotome | 2.95e-15 | 9 |
trunk paraxial mesoderm | 2.95e-15 | 9 |
musculature of body | 8.21e-14 | 10 |
dense mesenchyme tissue | 1.25e-12 | 11 |
paraxial mesoderm | 1.25e-12 | 11 |
presumptive paraxial mesoderm | 1.25e-12 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 6.41e-44 | 3 |
muscle cancer | 6.41e-44 | 3 |
organ system cancer | 1.89e-22 | 6 |